Yahoo Web Search

Search results

      • TARRYTOWN, New York, May 15, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (the “Company” or “PaxMedica”) (OTC:PXMD), a biopharmaceutical company dedicated to advancing treatments for neurological disorders, today announced it has timely filed a formal notice of appeal with the Nasdaq Office of Appeals and Review to reverse the decision of a Nasdaq Hearings Panel to delist the Company from Nasdaq.
  1. People also ask

  2. Find the latest PaxMedica, Inc. (PXMD) stock quote, history, news and other vital information to help you with your stock trading and investing.

  3. Get the latest PaxMedica, Inc. (PXMD) stock news and headlines to help you in your trading and investing decisions.

  4. 6 days ago · PXMD | Complete PaxMedica Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

    • 0.48%
    • 23.47%
    • 64.17%
    • 70.28%
  5. 5 days ago · Should You Buy or Sell PaxMedica Stock? Get The Latest PXMD Stock Analysis, Price Target, Headlines, and Short Interest at MarketBeat.

    • sprince@pcgadvisory.com
    • 6
  6. 4 days ago · Get a real-time PaxMedica, Inc. (PXMD) stock price quote with breaking news, financials, statistics, charts and more.

    • 18.50
    • 18.15M
    • 2.02M
    • 7.78M
  7. PaxMedica, Inc. Common Stock (PXMD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

  8. Get the latest PaxMedica Inc (PXMD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

  1. People also search for